CeraShield™ Coating Prevents Bacterial and Fungal Colonization, and Reduces Endotoxin
FDA Grants N8 Medical Breakthrough Device Designation
FDA Grants N8 Medical’s Request for Breakthrough Device Designation for its CeraShield™ Endotracheal Tube
New Research Shows CSA-131 has Potent Antifungal Activity
A recent published study by Professor Robert Bucki and colleagues has shown that CSA-131 has broad spectrum antifungal activity and retains activity in various body fluids.
Colistin Resistance on the Rise
Colistin is the last agent used to combat bacteria that are resistant to the strongest antibiotics. Colistin has remained the best tool available to treat multidrug resistant bacteria because bacteria were not exchanging genes for its resistance. Read more
CSA-131 Highly Effective against Colistin-resistant Strains
A recent published study by Professor Jordi Vila and his colleagues at the University of Barcelona, Spain has found that CSA-131 is highly effective against Colistin resistant strains of Pseudomonas and Acinetobacter.
